6J7-19305-66575
3 vaccinations
6 coded responses
28 check-ins
6 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 277 / NC
- Registered
- 2021-01-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Dose 1 — Pfizer-BioNTech
-
2021-01-09
Dose 2 — Pfizer-BioNTech
-
2021-01-11
Registered in v-safe
-
2021-01-11
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness · Fever · Headache, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-01-11
-
2021-01-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Itching · NoneAdult check-in
-
2021-01-13
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Itching · NoneAdult check-in
-
2021-01-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Itching · NoneAdult check-in
-
2021-01-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Itching · Fatigue or tirednessAdult check-in
- 2021-01-16
- 2021-01-23
- 2021-01-30
- 2021-02-06
- 2021-02-13
- 2021-02-20
-
2021-04-10
Survey response — 3 months, dose 2MedDRA: Asthma, Condition aggravated, Pre-existing disease — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Bronchitis and asthma flareMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-10
Report sent to call center — 3 months, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-09
- 2021-07-10
-
2021-09-28
Dose 3 — Pfizer-BioNTech
-
2021-09-29
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-09-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Itching · Fever · Fatigue or tirednessAdult check-in
-
2021-10-01
Survey response — days 1–6 daily, dose 3MedDRA: Hot flush — Feeling: Good · Site: Pain, ItchingFree text: Hot flashesMedDRA releases: 2024-11 · check-in free text available
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-12
- 2021-10-19
-
2021-10-26
Survey response — day 28, dose 3MedDRA: Cough, Oropharyngeal pain — Feeling: GoodFree text: Cough and sore throatMedDRA releases: 2024-11 · check-in free text available
-
2021-11-02
Survey response — day 35, dose 3MedDRA: Nasopharyngitis — Feeling: GoodFree text: Cold symptomsMedDRA releases: 2024-11 · check-in free text available
-
2021-11-09
Survey response — day 42, dose 3MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cold symptomsMedDRA releases: 2024-11 · check-in free text available
-
2021-12-28
Survey response — 3 months, dose 3MedDRA: Asthma, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Asthma exacerbationMedDRA releases: 2024-11 · check-in free text available
-
2021-12-28
Report sent to call center — 3 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
- 2022-01-03
- 2022-03-29
- 2022-09-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-09 | Pfizer-BioNTech | |
| 3 | 2021-09-28 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-11 | priority 2/3 | |
| 2021-04-10 | Unsuccessful | |
| 2021-12-28 | Unsuccessful |
Free text
Release 7 — 3 months, dose 2
Symptoms: Bronchitis and asthma flare
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Hot flashes
Release 10 — day 28, dose 3
Symptoms: Cough and sore throat
Release 10 — day 35, dose 3
Symptoms: Cold symptoms
Release 10 — day 42, dose 3
Symptoms: Cold symptoms
Release 10 — 3 months, dose 3
Symptoms: Asthma exacerbation
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthma | ✓ | ✓ | ✓ |
| SD | Condition aggravated | ✓ | ✓ | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Hot flush | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release